spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

3D Cell Culture 2018

SMi - 3D Cell Culture 2018

21-22 February 2018
Holiday Inn Kensington Forum, London UK

Building on the sell-out success of the launch event, SMi Group is delighted to announce the return of 3D Cell Culture, taking place on 21st and 22nd of February 2018, in London UK.

3D Cell Culture is rapidly growing with incredible potential for industrial application and a widespread reach that can be seen across many different fields, such as 3D bioprinting and microfluidics.

The 2nd annual conference will explore these overlapping areas and will combine pioneering breakthroughs with scientific research to strengthen your commercial success. Join us for exclusive insight into key topics such as disease models, organoids, organ-on-a-chip technologies, iPSC advances plus much more!

FEATURED SPEAKERS:

·        Gary Allenby, Business Development Director and Chief Scientific Officer, Aurelia Bioscience

·        Mr Stefan Przyborski, Scientific Founder, ReInnervate Limited

·        Mr Ricardo Baptista, Lead Scientist Process Development, Cell and Gene Therapy Catapult

·        Dr Nicholas Leslie, Tumour Biologist, Heriot-Watt University

·        Dr Suwan Jaysinghe, Professor of Bioengineering, University College London

·        Dr Max Salick, Postdoctoral Researcher, Novartis Institutes for Biomedical Research

·        Dr Patrick Kugelmeier, Director of Science, Kugelmeiers

·        Dr Vitor Santo, Senior Scientist, Immunocore

·        Mr Christopher Schofield, Investigator, GSK

·        Mr David Pan, Programme Manager (Regenerative Medicine), UK Regenerative Medicine Platform

·        Dr Reyk Horland,Head of Business Development, TissUse GmbH


REASONS TO ATTEND IN 2018

·        Uncover the biology of human neurodevelopment diseases in 3D by merging cutting edge technologies in CRISPR editing and single cell sequencing

·        Take a 3D biology approach to overcome challenges for well based screening with exclusive insight into electrospun micro-scaffold based biology

·        Develop strategies for optimising placement of cells in printing by identifying key developments in the overlap of 3D bioprinting and 3D cell culturing

·        Discover new approaches to predictive substance testing through innovative case study insight into multi-organ-chip technology

·        Benefit from an agenda tailored towards driving clinical development through ground breaking case studies on the Zika virus and tuberous sclerosis


2017 ATTENDEE TESTIMONIALS

“Very good presentations and a few outstanding ones... I made some useful contacts” ASTERAND BIOSCIENCE

“The conference was wonderfully organised” NOVARTIS

“Good start, love to see the event occur again” THERMO FISHER SCIENTIFIC

For further details visit www.3D-cellculture.com/samedan or contact the team on +44 (0)20 7827 6000

 

phone +44 (0)20 7827 6000
email events@smi-online.co.uk
web www.3D-cellculture.com/samedan
email Holiday Inn Kensington Forum, London UK
 
Print this page
Send to a friend
   
spacer
Industry Events

SMI Immuno-Oncology Conference

25-27 September 2018, Copthorne Tara Hotel, London, UK

Immuno-Oncology is a fast-paced field with massive potential to deliver successful and durable cancer therapies, and SMi's Immuno-Oncology Conference will focus on a few key areas of the field with a representation of the whole industry under each area. These areas will be drawn together to look towards the future of Immuno-oncology and how the field can progress.
More info >>

Banner of T3_events_97 on Samedan

White Papers

Managing GxP Environmental Systems to Ensure Data Integrity

Vaisala Ltd


More info >>


News and Press Releases

Charles River Laboratories Expands Services for Early Discovery Screening

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the expansion of its service capabilities in early discovery screening. Charles River is the first contract research organization to offer clients access to Apricot Designs' Dual Arm (ADDA) system for high-throughput absorption, distribution, metabolism, and excretion (HT-ADME) to identify potential lead compounds in North America and Europe. Additionally, the Company has geographically expanded its pharmacokinetic (PK) capabilities at sites central to major pharmaceutical and biotechnology hubs.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement